Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity (original) (raw)

Detection of T Helper Responses, But Not of Human Papillomavirus-Specific Cytotoxic T Lymphocyte Responses, After Peptide Vaccination of Patients With Cervical Carcinoma

Martin Kast

Journal of Immunotherapy, 2000

View PDFchevron_right

Targeting Immune Response with Therapeutic Vaccines in Premalignant Lesions and Cervical Cancer: Hope or Reality from Clinical Studies

Germano Zampa

Expert review of vaccines, 2016

View PDFchevron_right

Progress and controversies in developing cancer vaccines

Craig Slingluff

Journal of translational medicine, 2005

View PDFchevron_right

Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine

Gert Fleuren

Clinical Cancer Research, 2008

View PDFchevron_right

Tenth International Conference on Progress in Vaccination Against Cancer (PIVAC 10), Cambridge, UK, 27th–30th September 2010: New hopes and strategies for cancer vaccines

Stephanie McArdle

Cancer Immunology, Immunotherapy, 2011

View PDFchevron_right

Peptide-based vaccines for cancer immunotherapy

W. Martin Kast

Expert Opinion on Biological Therapy, 2004

View PDFchevron_right

Human Papillomavirus Immunogen That Provides Protective Tumor Immunity and Induces Tumor Regression

Juan Marquez

Viral Immunology, 2012

View PDFchevron_right

Advances in Peptide-based Human Papillomavirus Therapeutic Vaccines

Istvan Toth

Current Topics in Medicinal Chemistry, 2012

View PDFchevron_right

Trial Watch: Peptide vaccines in cancer therapy

Jérôme Galon, Alexander Eggermont

Oncoimmunology, 2013

View PDFchevron_right

A new era in anticancer peptide vaccines

Eric von Hofe

Cancer, 2010

View PDFchevron_right

Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity?

Mario Santinami

Cancer Immunology, Immunotherapy, 2009

View PDFchevron_right

The Present and Future of Peptide Vaccines for Cancer

Craig Slingluff

The Cancer Journal, 2011

View PDFchevron_right

Development of Peptide-Based Vaccines for Cancer

Chit Laa Poh

Journal of Oncology, 2022

View PDFchevron_right

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

Daphne Jansen, Mariet Feltkamp, Martin Kast

European Journal of Immunology, 1993

View PDFchevron_right

Clinical studies of human papilloma vaccines in cervical cancer

Alison Fiander

Advances in Experimental Medicine and Biology, 2001

View PDFchevron_right

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction

Cornelis Melief

Proceedings of the National Academy of Sciences, 1996

View PDFchevron_right

Therapeutic vaccination against human papilloma virus induced malignancies

Cornelis Melief

Current Opinion in Immunology, 2011

View PDFchevron_right

Progress on new vaccine strategies for the immunotherapy and prevention of cancer

Jay Berzofsky

Journal of Clinical Investigation, 2004

View PDFchevron_right

Cancer vaccines: a newer front of immunotherapy

praizy bhandari

International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 2018

View PDFchevron_right

Antitumor vaccination using peptide based vaccines

Lea Eisenbach

Immunology Letters, 2000

View PDFchevron_right

Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human papillomavirus type 16 oncoproteins genetically fused to …

Mariana Diniz

Clinical and Vaccine …, 2010

View PDFchevron_right

Peptide Vaccines For Cancer Therapy

Juan Sanctis

Recent patents on inflammation & allergy drug discovery, 2015

View PDFchevron_right

Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer

Alison Fiander

Vaccine, 2001

View PDFchevron_right

Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines

Cornelis Melief

Nature Reviews Cancer, 2008

View PDFchevron_right

Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection

Pramod Nehete

Vaccine, 2007

View PDFchevron_right